Variant · Fusion
FLT3 Fusion
CI-VAR-00001535Explore in graph →CIViC 5529
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 35019216
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Myeloid/Lymphoid Neoplasm1unmapped disease | ||||||||
| CCDC88C::FLT3 Fusion | (diagnostic) | Diagnostic | C | Supports Positive | 4 | submitted | EID13107This study describes a 50-year-old woman with peripheral eosinophilia and lymphadenopathy who was diagnosed with myeloid/lymphoid neoplasm with eosinophilia (MLN-eo) and T-lymphoblastic lymphoma. Both… (full text at CIViC) PMID 35019216 · Kurihara et al., 2022 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available
No ClinVar interpretation attached to this variant.